These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 20930287
21. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study. Benoit M, Robert PH, Staccini P, Brocker P, Guerin O, Lechowski L, Vellas B, REAL.FR Group. J Nutr Health Aging; 2005; 9(2):95-9. PubMed ID: 15791352 [Abstract] [Full Text] [Related]
22. [Prevalence and comorbidity of neuropsychiatric symptoms in Alzheimer's disease]. García-Alberca JM, Pablo Lara J, González-Barón S, Barbancho MA, Porta D, Berthier M. Actas Esp Psiquiatr; 2008; 36(5):265-70. PubMed ID: 18597200 [Abstract] [Full Text] [Related]
23. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study. van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT, Verhey FR. Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452 [Abstract] [Full Text] [Related]
24. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable? Kim JM, Lyons D, Shin IS, Yoon JS. Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174 [Abstract] [Full Text] [Related]
25. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Devanand DP. Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S3-8. PubMed ID: 10622673 [Abstract] [Full Text] [Related]
26. Prevalence of neuropsychiatric syndromes in Alzheimer's disease (AD). Youn JC, Lee DY, Jhoo JH, Kim KW, Choo IH, Woo JI. Arch Gerontol Geriatr; 2011 Nov; 52(3):258-63. PubMed ID: 20537736 [Abstract] [Full Text] [Related]
27. Category verbal fluency predicted changes in behavioral and psychological symptoms of dementia in patients with Alzheimer's disease. Tsai CF, Wang SJ, Zheng L, Fuh JL. Psychiatry Clin Neurosci; 2010 Aug; 64(4):408-14. PubMed ID: 20573053 [Abstract] [Full Text] [Related]
28. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia. Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):205-9. PubMed ID: 17020789 [Abstract] [Full Text] [Related]
29. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. Paulino Ramirez Diaz S, Gil Gregório P, Manuel Ribera Casado J, Reynish E, Jean Ousset P, Vellas B, Salmon E. Int J Geriatr Psychiatry; 2005 Aug 30; 20(8):744-8. PubMed ID: 16035121 [Abstract] [Full Text] [Related]
30. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia. De Deyn PP, Wirshing WC. J Clin Psychiatry; 2001 Aug 30; 62 Suppl 21():19-22. PubMed ID: 11584983 [Abstract] [Full Text] [Related]
31. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine]. Wobrock T, Retz-Junginger P, Retz W, Supprian T, Rösler M. Fortschr Neurol Psychiatr; 2003 Apr 30; 71(4):199-204. PubMed ID: 12677553 [Abstract] [Full Text] [Related]
32. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. Int J Geriatr Psychiatry; 2007 May 30; 22(5):475-84. PubMed ID: 17471598 [Abstract] [Full Text] [Related]
33. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice. Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):541-5. PubMed ID: 20184936 [Abstract] [Full Text] [Related]
34. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease. Spalletta G, Baldinetti F, Buccione I, Fadda L, Perri R, Scalmana S, Serra L, Caltagirone C. J Neurol; 2004 Jun 16; 251(6):688-95. PubMed ID: 15311344 [Abstract] [Full Text] [Related]
35. [Psychotic symptoms and Alzheimer's disease]. Alberca R, Gil-Néciga E, Salas D, Pérez JA, Lozano P. Neurologia; 2000 Jan 16; 15(1):8-14. PubMed ID: 10730061 [Abstract] [Full Text] [Related]
36. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study. Nagata T, Shinagawa S, Nakajima S, Plitman E, Mihashi Y, Hayashi S, Mimura M, Nakayama K. J Alzheimers Dis; 2016 Jan 16; 50(3):839-45. PubMed ID: 26836181 [Abstract] [Full Text] [Related]
37. [Main components of Neuropsychiatric Inventory in Alzheimer's disease. Definition of behavioral syndromes]. Amer-Ferrer G, de la Peña A, García Soriano MT, García Martín A. Neurologia; 2005 Jan 16; 20(1):9-16. PubMed ID: 15704016 [Abstract] [Full Text] [Related]
39. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan. Hsieh CJ, Chang CC, Lin CC. Int J Geriatr Psychiatry; 2009 Jun 16; 24(6):570-7. PubMed ID: 19051223 [Abstract] [Full Text] [Related]